Skip to content

Hypoxia and Heart Rate Variability

Hypoxia and Heart Rate Variability

Status
Withdrawn
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05606406
Enrollment
0
Registered
2022-11-04
Start date
2026-05-30
Completion date
2026-07-29
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxia, Pulmonary Disease, Chronic Obstructive

Brief summary

The purpose of this study is to evaluate how variations in oxygen demands may change heart electrical activity in individuals with and without oxygen dependence.

Interventions

Nocturnal oxygen will be increased hourly for a period of four hours up to 4 liters per minute (LPM). If the oxygen saturation (SpO2) falls below 70% the oxygen rate will be increased until patients achieve the threshold of 70% and then will proceed with titrations of 1 liter per minute LPM per hour.

Sponsors

University of Miami
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

Healthy Participants Inclusion Criteria: • Ability to provide consent

Exclusion criteria

* BMI \> 40 kg/m2 * Prevalent myocardial infarction, coronary revascularization, heart failure, and stroke * Unstable medical conditions that may preclude enrollment in the protocol such as: uncontrolled angina and/or congestive heart failure, uncontrolled blood pressure or resistant hypertension, cancer, and active psychiatric disease (e.g., major depression) Nocturnal Hypoxemia Inclusion Criteria: * Ability to provide consent * Chronic respiratory condition resting Sat \< 95% off oxygen

Design outcomes

Primary

MeasureTime frameDescription
QT Variability IndexUp to 10 hoursMeasured from electrocardiogram (ECG)

Secondary

MeasureTime frameDescription
Normalized variance of the heart rate (HRVN)Up to 10 hoursMeasured from ECG
QT-RR intervalUp to 10 hoursMeasured from ECG

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORTrishul Siddharthan, MD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 4, 2026